Editor's Correspondence |

Problems With Measuring the Use of β-Blockers in Ambulatory Settings for Secondary Prevention in Patients With Coronary Artery Disease

Thomas J. Wang, MD; Randall S. Stafford, MD, PhD
Arch Intern Med. 1999;159(7):755-756. doi:.
Text Size: A A A
Published online


In reply

Given the inherent difficulties encountered in assessing national patterns of outpatient practice, it is not surprising that Drs Kakaiya and Warnhoff identify several limitations of our analysis, as well as areas of possible misunderstanding. While reinforcing the need for caution in interpreting our findings, their comments do not invalidate our conclusion that the use of β-blockers in coronary artery disease appears to be suboptimal.

Kakaiya and Warnhoff may have misunderstood several aspects of our methods. For instance, our analyses did not rely on patient recollection because survey forms were filled out by physicians, not patients. Furthermore, the coded medication lists include all medications regardless of how they were obtained (office sample or pharmacy bought). Second, our sample sizes were large enough to make annual estimates of β-blocker usage. The year with the fewest visits was 1996, where 710 visits were available for analysis. Annual rates of β-blocker use did rise, from 17% in 1993 to 25% in 1996, a point we highlight in the discussion and Figure 1 of our article.1 Even so, we found it surprising that in 1996 three fourths of patients with a diagnosis of coronary artery disease were not on a regimen that included β-blockers.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles